The researchers looked examined the effect of different polymorphisms in the TNF and TLR4 genes on anti-TNF medication therapeutic efficacy in 190 Caucasian patients with HS (from Greece), 32 of which were medicated with ADA. The gene discussed is TNF; the disease is histiocytic sarcoma.